Virtu Financial
AZR

Virtu Financial’s Azora Therapeutics, Inc. Common Stock AZR Stock Holding History

Virtu Financial’s Portfolio AZR Stock Details AZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,553
Closed -$14K – 1572
2025
Q4 		$14K Buy
+2,553
New +$20.7K ﹤0.01% 1476
2025
Q2 		– Sell
-1,057
Closed -$17K – 1391
2025
Q1 		$17K Buy
+1,057
New +$21.8K ﹤0.01% 1120
2024
Q2 		– Sell
-819
Closed -$27K – 1242
2024
Q1 		$27K Buy
+819
New +$30.7K ﹤0.01% 1124
2023
Q3 		– Sell
-42
Closed -$6K – 1224
2023
Q2 		$6K Sell
42
-32
-43% -$5.78K ﹤0.01% 1386
2023
Q1 		$16K Sell
74
-66
-47% -$16K ﹤0.01% 1284
2022
Q4 		$19K Buy
140
+16
+13% +$2.8K ﹤0.01% 1278
2022
Q3 		$27K Buy
124
+73
+143% +$32.9K ﹤0.01% 1338
2022
Q2 		$43K Buy
+51
New +$46.2K ﹤0.01% 1158
2021
Q3 		– Sell
-50
Closed -$79K – 1441
2021
Q2 		$79K Buy
+50
New +$76.1K 0.01% 1253
2020
Q4 		– Sell
-30
Closed -$42K – 1398
2020
Q3 		$42K Buy
+30
New +$27.9K 0.01% 842

Other funds holding AZR

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Manchester Capital Management
Manchester Capital Management Manchester, Vermont $736M AUM 20.83% 1-Year Est. Return
Tower Research Capital (TRC)
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Raffa Wealth Management
Raffa Wealth Management Washington, District of Columbia $793M AUM 13.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Virtu Financial's AZR Position: Q1 2026 in Review

Virtu Financial sold out of Azora Therapeutics, Inc. Common Stock (AZR) in Q1 2026, closing a stake of 2,553 shares — an estimated $14K sold.

Virtu Financial first reported a position in AZR in Q3 2020 and held it in 10 quarters. The position peaked at $79K in Q2 2021. 15 funds tracked by Wall St. Rank hold AZR as of Q1 2026.

  • Virtu Financial reported no remaining Azora Therapeutics, Inc. Common Stock position as of Q1 2026 after selling out during the quarter.
  • Virtu Financial sold 2,553 Azora Therapeutics, Inc. Common Stock shares in Q1 2026, an estimated $14K.
  • Virtu Financial first reported a position in Azora Therapeutics, Inc. Common Stock in Q3 2020 and held it in 10 quarters.
  • Virtu Financial's Azora Therapeutics, Inc. Common Stock position peaked at $79K in Q2 2021.
  • 15 funds tracked by Wall St. Rank held Azora Therapeutics, Inc. Common Stock as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.